Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 11:45 PM
Study NCT ID:
NCT05405894
Status:
UNKNOWN
Last Update Posted:
2024-05-14
First Post:
2022-05-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Sponsor:
University of Calgary
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
REB21-1898
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None